Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Janux Therapeutics, Inc. (JANX) Debt to Equity Ratio data is not available.
| Income Statement Financials | |
$10.00M |
|
$-24.31M |
|
-- |
|
$10.00M |
|
$45.25M |
|
$-35.25M |
|
$10.94M |
|
$-24.31M |
|
$-24.31M |
|
$-24.31M |
|
$-24.31M |
|
$-24.31M |
|
$-24.31M |
|
$-35.25M |
|
$-39.37M |
|
62.02M |
|
62.02M |
|
$-0.39 |
|
$-0.39 |
|
| Balance Sheet Financials | |
$998.09M |
|
$4.31M |
|
$26.68M |
|
$1.02B |
|
$27.83M |
|
-- |
|
$20.38M |
|
$48.21M |
|
$976.56M |
|
$976.55M |
|
$976.55M |
|
60.12M |
|
| Cash Flow Statement Financials | |
$-53.69M |
|
$-330.52M |
|
$2.00M |
|
$431.42M |
|
$49.20M |
|
$-382.22M |
|
$30.71M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
35.86 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
-- |
100.00% |
|
-352.51% |
|
-352.51% |
|
-- |
|
-243.13% |
|
-243.13% |
|
$-54.63M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-2.49% |
|
-2.49% |
|
-2.37% |
|
-2.49% |
|
$16.24 |
|
$-0.88 |
|
$-0.87 |
|